Emerging trends in Sjögren's syndrome: basic and translational research
Alessia Gallo1, Chiara Baldini, Leyla Teos
1National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA. alessia.gallo@nih.gov
Clinical and Experimental Rheumatology
|September 27, 2012
Summary
This review explores new biomarkers for primary Sjögren's syndrome (pSS) and evaluates gene transfer's potential to restore salivary gland function. Discover the latest advancements in diagnosing and treating this autoimmune condition.
Area of Science:
- Autoimmune diseases
- Genomics
- Proteomics
- Salivary gland biology
Background:
- Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands, leading to dryness.
- Current diagnostic and therapeutic strategies for pSS have limitations, necessitating the exploration of novel approaches.
- Understanding the molecular mechanisms underlying pSS is crucial for developing targeted treatments.
Purpose of the Study:
- To review the current state of novel genomic and proteomic biomarkers for pSS.
- To assess the potential of gene transfer technology for restoring salivary gland function in pSS.
- To provide insights into future research directions for pSS diagnosis and treatment.
Main Methods:
- Comprehensive literature search of peer-reviewed articles on pSS biomarkers and gene therapy.
- Analysis of 'state of the art' genomic and proteomic findings in pSS.
- Evaluation of preclinical and clinical studies on gene transfer to salivary glands.
Main Results:
- Emerging genomic and proteomic biomarkers show promise for early pSS diagnosis and patient stratification.
- Gene transfer strategies are being investigated to restore aquaporin and other functional gene expression in salivary glands.
- Preclinical studies demonstrate the feasibility of gene therapy in animal models of salivary dysfunction.
Conclusions:
- Novel biomarkers offer new avenues for pSS diagnosis and personalized medicine.
- Gene transfer holds therapeutic potential for salivary gland hypofunction in pSS.
- Further research is needed to translate these findings into clinical practice for improved patient outcomes.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...